This article was originally published on MedTech Intelligence. Driven by an aging population with growing needs for new medical technologies—and more means to pay for them—governments and hospitals in China, Japan, Singapore, Thailand and Korea are joining forces to purchase an increasing... Read More
Continuing its push to encourage the development of artificial intelligence (AI) products, South Korea is making it simpler for manufacturers to secure government approval of AI-based medical devices. In October, the Ministry of Food and Drug Safety announced that it would ease... Read More
Chronic health disorders linked to obesity, smoking, high salt intake, and pollution are mounting in China, as Asia’s largest economy grapples with the burdens of rapid growth and affluence. A new study published in the Lancet finds chronic illnesses including stroke, hypertension,... Read More
One month after the Philippines health authorities recommended capping retail prices of 120 needed drugs that are more costly in the archipelago nation than on average elsewhere, major pharmaceutical companies are in talks to reduce prices on some drugs voluntarily. In a... Read More
With the goal of raising the quality and accessibility of its healthcare system to a level commensurate with its position as the world’s second-largest economy, the Chinese government has in the past five years doubled the money it pours into public hospitals... Read More
Despite renewed government efforts to bring South Korea’s historically elevated rate of tuberculosis under control, the nation still has the highest incidence rate of the disease among the world’s wealthiest countries – nations that belong to the 34-member Organization for Economic Cooperation and... Read More
Spiraling trade tensions between the U.S. and China are injecting uncertainty into what was already a complex environment for MedTech manufacturers. Accelerating steps, some medical technology firms have already been starting to move their operations to other countries in the region. Directly... Read More
China’s ambitious campaign to expand healthcare coverage and access to innovative drugs is making its pharmaceutical market an increasingly key source of growth for foreign firms. But even as the more than $135 billion pharmaceutical markets in the Asian giant surpasses that... Read More
Spending on cancer drugs is dominating health spending in China, with hospitals in 2018 purchasing more cancer and immunomodulatory drugs than anti-infective drugs for the first time ever. According to data from the China Pharmaceutical Association (CPA), anti-tumor and immunomodulatory treatments represented... Read More
Fueled by high sugar diets, processed food, misinformation and a dearth of early intervention, the prevalence of Type 2 diabetes is a persistent public health crisis in Southeast Asia. One of every 14 people in Indonesia, Malaysia, Singapore, and Thailand has some... Read More